Novo-Glyburide | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Novo-Glyburide
EDQM

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Contact Supplier

Evonik

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Novo-Glyburide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 15 USDMF, 9 CEP/COS, 4 JDMF, 6 EU WC, 1 KDMF, 6 NDC API, 16 Listed Suppliers, $ API Reference Price

30 API Suppliers
15 USDMF
9 CEP/COS
4 JDMF
6 EU WC
1 KDMF
6 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

INTERMEDIATES

10 Intermediate Suppliers

10 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

178 FDF Dossiers, 83 FDA Orange Book, 20 Europe, 7 Canada, 2 Australia, 19 South Africa, 47 Listed Dossiers

178 FDF Dossiers
83 FDA Orange Book
20 Europe
7 Canada
2 Australia
19 South Africa
47 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1.25MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 1.25MG
TABLET;ORAL - 2.5MG
TABLET;ORAL - 5MG
TABLET;ORAL - 1.25MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Evonik, 7 SPI Pharma, 8 DKSH, 6 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 Avesta Pharma, 27 BASF, 2 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 6 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

81 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 36 Controlled & Modified Release, 32 Direct Compression, 29 Solubilizers, 28 Thickeners and Stabilizers, 27 Disintegrants & Superdisintegrants, 26 Granulation, 20 Film Formers & Plasticizers, 18 Lubricants & Glidants, 18 Topical, 15 Co-Processed Excipients, 12 Parenteral, 11 Taste Masking, 9 Emulsifying Agents, 8 Chewable & Orodispersible Aids, 8 Rheology Modifiers, 6 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

81 Fillers, Diluents & Binders
49 Coating Systems & Additives
36 Controlled & Modified Release
32 Direct Compression
29 Solubilizers
28 Thickeners and Stabilizers
27 Disintegrants & Superdisintegrants
26 Granulation
20 Film Formers & Plasticizers
18 Lubricants & Glidants
18 Topical
15 Co-Processed Excipients
12 Parenteral
11 Taste Masking
9 Emulsifying Agents
8 Chewable & Orodispersible Aids
8 Rheology Modifiers
6 API Stability Enhancers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

26 News #PharmaBuzz

26 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 27 Regulatory FDF Prices

2 US Medicaid Prescriptions
27 Regulatory FDF Prices

MARKET PLACE

15 APIs, 5 FDF Dossiers

15 APIs
5 FDF Dossiers

REF. STANDARDS & IMPURITIES

4 EDQM, 4 Others

4 EDQM
4 Others

$ API Ref.Price (USD/KG) : 84 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

4 All

01 1G0325000

02 1G0325010

03 1Y0000242

04 1Y0001511

filter CAS Number Reset all filters

4 All

01 210238-21-8

02 2n/a

filter Reference Standard Reset all filters

4 All

01 1Glibenclamide

02 1Glibenclamide for peak identification

03 1Glibenclamide impurity A

04 1Glibenclamide impurity B

Product Main Page

01

EDQM, Council of Europe

Glibenclamide for peak identification

Arvo

Not Confirmed

01

EDQM, Council of Europe

Arvo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Glibenclamide for peak identification

CAS Number : 10238-21-8

Quantity Per Vial : 30 mg

Sale Unit : 1

Order Code : Y0001511

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Glibenclamide impurity B

Arvo

Not Confirmed

02

EDQM, Council of Europe

Arvo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Glibenclamide impurity B

CAS Number : n/a

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0000242

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Glibenclamide impurity A

Arvo

Not Confirmed

03

EDQM, Council of Europe

Arvo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Glibenclamide impurity A

CAS Number : n/a

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : G0325010

Batch No : 4

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EDQM, Council of Europe

Glibenclamide

Arvo

Not Confirmed

04

EDQM, Council of Europe

Arvo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Glibenclamide

CAS Number : 10238-21-8

Quantity Per Vial : 100 mg

Sale Unit : 1

Order Code : G0325000

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!